Carlo Garofalo

Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial

Michele Provenzano, María Jesús Puchades, Carlo Garofalo et al. · Journal of the American Society of Nephrology · 2022 · 176 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies

Roberto Minutolo, Francis B. Gabbai, Michele Provenzano et al. · Nephrology Dialysis Transplantation · 2018 · 91 citations · Full text

Medicine, Internal Medicine, Nephrology +17

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies

Roberto Minutolo, Francis B. Gabbai, Paolo Chiodini et al. · American Journal of Kidney Diseases · 2019 · 88 citations

Medicine, Geriatric Medicine, Nephrology +16